Keywords: baxter, market, halozyme, rhuph20, therapeutics, signed, exclusive

Baxter to market Halozyme's rHuPH20

Article | 23 August 2004

Print This

Halozyme Therapeutics has signed an exclusive deal with fellow US firmBaxter Healthcare under which the latter will market, distribute and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in